SYNGENE — Syngene International Share News
0.000.00%
Last trade - 00:00- IN₹167.75bn
- IN₹160.76bn
- IN₹37.39bn
Emergent BioSolutions drops after Syngene buys co's unit for $36.5 mln
Brief: Syngene International To Invest Up To USD 56 Million In Syngene USA
Brief: Syngene International Acquires First Biologics Site In USA
India's Syngene International acquires first US biologics facility for $50 mln
Brief: Syngene International Says Penalty Proceedings For 32.6 Million Rupees Dropped
India's contract drug makers seek government support in China fight
Brief: Syngene International Says Tax Demand Order Reduced To 102 Million Rupees
Brief: Syngene International Says Jonathan Hunt Steps Down As MD & CEO Of Syngene
Brief: Syngene International Says Aggregate Tax Amount Under Government Scheme To Be Paid Is 94.7 Mln Rupees
Indian drugmaker Anthem Biosciences files for $397 mln IPO (updated)
Brief: Biocon Sells 8 Mln Shares Of Syngene International Through Block Deal
India's Syngene International rises after report Biocon likely to sell stake
Brief: Syngene International Gets Order Modifying Tax Demand To 25.9 Mln Rupees
Brief: Syngene International Sept-Quarter Consol Profit 1.06 Bln Rupees
Brief: Syngene International Got Tax Refund Order For 136 Million Rupees
Brief: Syngene International June-Quarter Consol Profit 757 Million Rupees
Brief: Syngene International Re-Appoints Jonathan Hunt As MD, CEO
India's Syngene, Neuland Labs rise as Goldman sets Street-high PTs
Brief: Syngene International Gets 3 Orders Seeking Tax And Interest Totalling 120.9 Mln Rupees